Stephen H. Dinwiddie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stephen H. Dinwiddie has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Brendan J. Beresford
Department of Psychiatry, University of Chicago, IL 60637-1470, USA
1 shared publicationDavid Glick
1 shared publicationDeborah Spitz
1 shared publicationDezheng Huo
From the *Department of Psychiatry and Behavioral Neuroscience, University of Chicago Pritzker School of Medicine, †Department of Health Studies, University of Chicago, and ‡Department of Anesthesia and Critical Care, University of Chicago Pritzker School of Medicine, Chicago, IL
1 shared publicationElliot S. Gershon
Department of Psychiatry, University of Chicago, Chicago, IL, USA
1 shared publicationJinger Hoop
Department of Psychiatry, University of Chicago, Chicago, IL, USA
1 shared publication
Latest Publications
- 1 December 2010
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 26 (4) , 310-316
Resident Education in Electroconvulsive Therapy
In 2001, the American Psychiatric Association's Task Force on electroconvulsive therapy (ECT) recommended that psychiatry residents should receive at least 4 hours of didactic instruction on ECT, participate in at least 10 treatments, and assist in the care of at least 3 patients receiving ECT. Residency accreditation requirements as of 2007, however, require only that training programs ensure competency in "understanding the indications and uses" of ECT. Anecdotally, training in ECT is said to vary widely between residency programs. The purpose of the study was to obtain more systematic information about ECT training. A survey was e-mailed to directors of all accredited psychiatry residency programs in the United States and Puerto Rico in early to mid 2008, requesting information regarding their didactic and clinical instruction in ECT and estimates of number of treatments provided by their institutions. Responses were obtained from 91 training programs. Of these programs, 75% reported that some clinical exposure to ECT was required of their residents, but 37% estimated that the typical resident would participate in fewer than 10 treatments and 27% estimated that the typical resident would care for fewer than 5 patients receiving ECT. Most programs devoted less than 4 hours of lecture time to ECT. Most respondents believed that ECT was underused nationally; this perception did not differ based on the theoretical orientation of the training program. This study suggests that resident education in ECT varies considerably between programs but is often less than that suggested by the American Psychiatric Association's Task Force.
- 1 December 2010
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 26 (4) , 310-316
Resident Education in Electroconvulsive Therapy
In 2001, the American Psychiatric Association's Task Force on electroconvulsive therapy (ECT) recommended that psychiatry residents should receive at least 4 hours of didactic instruction on ECT, participate in at least 10 treatments, and assist in the care of at least 3 patients receiving ECT. Residency accreditation requirements as of 2007, however, require only that training programs ensure competency in "understanding the indications and uses" of ECT. Anecdotally, training in ECT is said to vary widely between residency programs. The purpose of the study was to obtain more systematic information about ECT training. A survey was e-mailed to directors of all accredited psychiatry residency programs in the United States and Puerto Rico in early to mid 2008, requesting information regarding their didactic and clinical instruction in ECT and estimates of number of treatments provided by their institutions. Responses were obtained from 91 training programs. Of these programs, 75% reported that some clinical exposure to ECT was required of their residents, but 37% estimated that the typical resident would participate in fewer than 10 treatments and 27% estimated that the typical resident would care for fewer than 5 patients receiving ECT. Most programs devoted less than 4 hours of lecture time to ECT. Most respondents believed that ECT was underused nationally; this perception did not differ based on the theoretical orientation of the training program. This study suggests that resident education in ECT varies considerably between programs but is often less than that suggested by the American Psychiatric Association's Task Force.
- 1 June 2010
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 26 (2) , 116-120
The Course of Myalgia and Headache After Electroconvulsive Therapy
Background: Headache and myalgia seem to be common, though generally mild, complications of electroconvulsive therapy. Relatively little is known regarding the usual severity and time course of these complaints. Objective: This study examines the incidence, severity, and time course of myalgia and headache after electroconvulsive therapy. Methods: Patients rated severity of myalgia and headache immediately before treatment and again after recovery and at 2, 6, 12, and 24 hours posttreatment on a 10-point visual analog scale. Data were analyzed using random-effects linear models. Results: Severity of headache peaked 2 hours after treatment, returning to baseline by 24 hours and was relatively consistent within individuals between treatments. More severe posttreatment headache was reported by patients with a history of incapacitating headache and by those younger than 45 years. Headache was associated with increased duration of seizure. By contrast, myalgia was substantially more pronounced and lasted longer after the first treatment as compared with subsequent treatments. Severity of myalgia was not predicted by degree of fasciculations or motor activity, but was worse in patients younger than 45 years. Conclusions: Posttreatment headache and myalgia are common but usually mild. Routine pretreatment using non-depolarizing agents is probably unnecessary in most cases but may have a role during the first treatment in a series. By contrast, preventive treatment may be warranted in those with history of severe headache and those who previously have had significant post-ECT headache.
- 1 June 2010
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 26 (2) , 116-120
The Course of Myalgia and Headache After Electroconvulsive Therapy
Background: Headache and myalgia seem to be common, though generally mild, complications of electroconvulsive therapy. Relatively little is known regarding the usual severity and time course of these complaints. Objective: This study examines the incidence, severity, and time course of myalgia and headache after electroconvulsive therapy. Methods: Patients rated severity of myalgia and headache immediately before treatment and again after recovery and at 2, 6, 12, and 24 hours posttreatment on a 10-point visual analog scale. Data were analyzed using random-effects linear models. Results: Severity of headache peaked 2 hours after treatment, returning to baseline by 24 hours and was relatively consistent within individuals between treatments. More severe posttreatment headache was reported by patients with a history of incapacitating headache and by those younger than 45 years. Headache was associated with increased duration of seizure. By contrast, myalgia was substantially more pronounced and lasted longer after the first treatment as compared with subsequent treatments. Severity of myalgia was not predicted by degree of fasciculations or motor activity, but was worse in patients younger than 45 years. Conclusions: Posttreatment headache and myalgia are common but usually mild. Routine pretreatment using non-depolarizing agents is probably unnecessary in most cases but may have a role during the first treatment in a series. By contrast, preventive treatment may be warranted in those with history of severe headache and those who previously have had significant post-ECT headache.
- 1 November 2004
- Published by Taylor & Francis in International Review of Psychiatry
- Vol. 16 (4) , 320-328
Ethical issues in the use of genetic information
Advances in molecular genetics promise to deepen our understanding of the biological basis of human behavior and shed light on the pathophysiology of mental illness. Genetic research is likely to improve our ability to develop somatic treatments for psychiatric syndromes as well as to identify targets for environmental intervention. However, population-screening tests for disorders with multifactorial inheritance may offer little clinical benefit to outweigh their potential for misuse. Relevant legal issues surrounding the use of genetic information in psychiatry include the perceived need for laws to prevent insurance and employment discrimination, and concerns about genetic status as a possible excuse for criminal behavior. Relevant ethical issues include threats to patient privacy and confidentiality and the importance of fairly distributing the benefits and burdens of genetic advances.
- 1 November 2004
- Published by Taylor & Francis in International Review of Psychiatry
- Vol. 16 (4) , 320-328
Ethical issues in the use of genetic information
Advances in molecular genetics promise to deepen our understanding of the biological basis of human behavior and shed light on the pathophysiology of mental illness. Genetic research is likely to improve our ability to develop somatic treatments for psychiatric syndromes as well as to identify targets for environmental intervention. However, population-screening tests for disorders with multifactorial inheritance may offer little clinical benefit to outweigh their potential for misuse. Relevant legal issues surrounding the use of genetic information in psychiatry include the perceived need for laws to prevent insurance and employment discrimination, and concerns about genetic status as a possible excuse for criminal behavior. Relevant ethical issues include threats to patient privacy and confidentiality and the importance of fairly distributing the benefits and burdens of genetic advances.
- 1 June 2004
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 20 (2) , 120-122
Combination Propofol–Alfentanil Anesthesia for Electroconvulsive Therapy in Patients Receiving Monoamine Oxidase Inhibitors
Two patients who had failed outpatient treatment of depression were given electroconvulsive therapy while simultaneously being treated with monoamine oxidase inhibitors. Both were administered propofol–alfentanil anesthesia without complications.
- 1 June 2004
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 20 (2) , 120-122
Combination Propofol–Alfentanil Anesthesia for Electroconvulsive Therapy in Patients Receiving Monoamine Oxidase Inhibitors
Two patients who had failed outpatient treatment of depression were given electroconvulsive therapy while simultaneously being treated with monoamine oxidase inhibitors. Both were administered propofol–alfentanil anesthesia without complications.
- 1 January 2004
- Published by Elsevier in International Journal of Law and Psychiatry
- Vol. 27 (1) , 17-29
Prosecution of violent psychiatric inpatients: Theoretical and practical issues
- 1 January 2004
- Published by Elsevier in International Journal of Law and Psychiatry
- Vol. 27 (1) , 17-29
Prosecution of violent psychiatric inpatients: Theoretical and practical issues